Natera · 18 hours ago
Regional Medical Director - Skin/IO
United States
Full-time
Remote
Lead/Staff, Director/Executive
$222K/yr - $277K/yr
5+ years expNatera is a global leader in cell-free DNA testing dedicated to oncology, women's health, and organ health. In this strategic leadership role, you will provide medical expertise and scientific leadership across Natera's oncology portfolio, focusing on melanoma, cutaneous malignancies, and immunotherapy applications across solid tumors.
BiotechnologyGeneticsHealth DiagnosticsMedicalWomen's
Responsibilities
Lead the clinical strategy and evidence generation for melanoma, non-melanoma skin cancers, and pan-tumor immunotherapy indications
Partner closely with clinical development, medical affairs, and commercial teams to translate emerging evidence into meaningful clinical practice applications
Collaborate with key opinion leaders (KOLs), cooperative groups, and academic investigators to validate and expand clinical use cases for ctDNA-based diagnostics in immuno-oncology
Provide field-facing education and strategic guidance to healthcare providers, payers, and advocacy organizations on clinical utility, interpretation, and impact of MRD and response monitoring in immune-treated populations
Identify and address barriers to adoption by aligning evidence generation, messaging, and stakeholder engagement with evolving standards of care and health system needs
Serve as the medical and scientific spokesperson for skin and immuno-oncology programs, communicating clinical utility, study data, and product value to external experts and stakeholders
Partner with commercial teams to develop educational resources, medical content, and scientific training for healthcare providers and internal teams
Provide scientific leadership during advisory boards, symposia, and investigator meetings
Represent Natera at national and international oncology and immunotherapy conferences, fostering relationships with key opinion leaders in melanoma and IO
Promote a culture of scientific rigor and innovation within the medical affairs and R&D organizations
Collaborate on clinical trial design, data analysis, and publication strategy related to ctDNA applications in melanoma and other immune-responsive solid tumors
Identify and cultivate academic and cooperative group partnerships to advance clinical validation and translational research in skin and pan-tumor immuno-oncology
Deep clinical knowledge of melanoma and cutaneous oncology, including evolving standards of care, targeted therapy, and checkpoint inhibitor use
Expertise in immunotherapy mechanisms, response kinetics, and biomarker development across multiple solid tumor types
Provide expert medical guidance on immunotherapy-specific diagnostic development and clinical implementation
Ability to engage across tumor types to support Natera’s broad oncology portfolio
Maintain awareness of emerging trends in liquid biopsy, precision medicine, and immune response monitoring
Work collaboratively with research, development, commercial, and medical affairs to align medical strategy with business objectives
Partner with regulatory and clinical operations teams to ensure compliance, data quality, and clinical relevance
Qualification
Required
MD. or D.O. degree with board certification in Medical Oncology
Preferred
At least 5 years of experience in oncology, with clinical or research experience in melanoma, skin cancers, or immunotherapy
Strong publication or clinical trial background in immuno-oncology or translational oncology research
Benefits
Comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents
Free testing in addition to fertility care benefits
Pregnancy and baby bonding leave
401k benefits
Commuter benefits
Generous employee referral program
Company
Natera
Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.
5001-10000 employees
H1B Sponsorship
Natera has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (90)
2024 (72)
2023 (37)
2022 (71)
2021 (64)
2020 (40)
Funding
Current Stage
Public CompanyTotal Funding
$1.16BKey Investors
Sofinnova InvestmentsLightspeed Venture PartnersSequoia Capital
2023-09-07Post Ipo Equity· $250M
2022-11-15Post Ipo Equity· $400.05M
2022-03-16Post Ipo Equity· $5M
Leadership Team
Steve Chapman
CEO
Jonathan Sheena
Co-Founder, Board Member
Recent News
2026-01-22
Business Wire
2026-01-22
2026-01-22
Company data provided by crunchbase